A Textbook of Clinical Pharmacology and Therapeutics
A Textbook of Clinical Pharmacology and Therapeutics
A Textbook of Clinical Pharmacology and Therapeutics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
non-steroidal anti-inflammatory drugs 167–9<br />
asthma 168–9, 243<br />
elderly patients 60<br />
eye 427<br />
hyperkalaemia 280<br />
methotrexate <strong>and</strong> 375<br />
peptic ulcers 247, 249, 252<br />
post-operative pain 163<br />
renal failure 37<br />
topical 158<br />
warfarin <strong>and</strong> 208<br />
norelgestromin 308<br />
norethisterone 308<br />
ciclosporin <strong>and</strong> 402<br />
nortestosterone derivatives 308<br />
nose, drug absorption 21<br />
nucleoside analogue reverse transcriptase<br />
inhibitors 353–4<br />
nucleoside analogues 345–7<br />
nucleotide reverse transcriptase inhibitor 354<br />
nystatin 341<br />
obesity 262–3<br />
atheroma 179<br />
oblimersen 382<br />
obstructive uropathy<br />
�-adrenoceptor antagonists for 280<br />
drug-induced 69<br />
occlusion, drugs <strong>and</strong> skin 20, 22<br />
occupational hazards, inhalational anaesthetics<br />
147–8<br />
octreotide 316–17<br />
oesophageal varices 261, 317<br />
oedema 211<br />
oesophageal varices 261<br />
octreotide 261, 317<br />
oesophagitis<br />
bisphosphonates 299<br />
reflux 252<br />
pregnancy 49<br />
oestrogens 307–8<br />
with cyproterone for acne 411<br />
hormone replacement therapy 311, 312<br />
on liver 262<br />
for malignant disease 384<br />
malignant disease from 308<br />
thrombosis 204–5<br />
see also phytoestrogens<br />
olanzapine 114<br />
olsalazine 19, 255<br />
omalizumab, asthma 235, 241<br />
omeprazole 251<br />
on-<strong>of</strong>f phenomena, levodopa 125<br />
onchocerciasis, drug for 366<br />
oncogenes 367<br />
ophthalmopathy, Graves’ 295<br />
opioids 159–64<br />
abuse 434–7<br />
for anaesthesia 149–50<br />
antagonists 10, 162<br />
compounds with paracetamol 448–9<br />
for diarrhoea 258<br />
on fetus 48<br />
hypothyroidism 39<br />
intensive care 150<br />
liver disease 261<br />
poisoning 446<br />
pregnancy 48–9<br />
receptors 159–60<br />
opportunistic infections<br />
HIV infection 357–9<br />
immunosuppression 400<br />
oprelvekin 394<br />
oral contraceptives<br />
combined 308–10, 311, 315<br />
see also contraceptives (hormonal)<br />
oral hypoglycaemic agents 288–90<br />
elderly patients 59<br />
oral rehydration preparations 258<br />
oral route 18, 19–20<br />
absorption via 17<br />
liquid preparations 52, 54<br />
presystemic metabolism 17, 18, 28–9<br />
organic anions <strong>and</strong> cations, proximal tubular<br />
secretion 31–2<br />
organogenesis 46<br />
organophosphates 449<br />
orlistat 263–4, 265<br />
oseltamivir phosphate 348<br />
Osmosin 20<br />
osmotic diuretics 276<br />
osmotic laxatives 257<br />
osteoarthritis, glucosamine 101<br />
osteomalacia 300<br />
osteoporosis 297, 300<br />
heparin 206<br />
pregnancy 50<br />
oestrogens 307, 311<br />
ototoxicity<br />
aminoglycosides 328<br />
cisplatin 373–4<br />
furosemide 275<br />
overdoses<br />
aspirin 157, 158<br />
barbiturates 442<br />
Cafergot 144<br />
iron preparations 390<br />
local anaesthetics 153<br />
opioids 435<br />
paracetamol 27, 30, 156, 445, 446–7<br />
dextropropoxyphene with 448–9<br />
self-poisoning 444–9<br />
overhydration 276–7<br />
ovulation, induction 317<br />
oxaliplatin 374<br />
oxidation 25<br />
microsomal 24–5<br />
oxybutynin 279<br />
oxygen therapy<br />
bleomycin lung 385<br />
chronic obstructive pulmonary disease 236<br />
myocardial infarction 198<br />
respiratory failure 241–2<br />
oxytocin 312–13, 318<br />
paclitaxel 379–80<br />
Paget’s disease, bisphosphonates 299<br />
pain 155, 156<br />
adenosine 226<br />
post-operative 163–4<br />
terminal disease 162–3<br />
see also analgesics<br />
pancreatic enzyme replacement 259<br />
H2-receptor antagonists <strong>and</strong> 250, 259<br />
pancreatic insufficiency 259<br />
pancreatin 259<br />
pancreatitis, drugs associated 259<br />
pancuronium 151<br />
papaverine 159<br />
papilloma virus 417<br />
para-aminohippuric acid 31–2<br />
para-aminosalicylic acid (PAS) 338<br />
paracetamol 156<br />
migraine 142<br />
overdoses 27, 30, 156, 445, 446–7<br />
co-proxamol 448–9<br />
parallel-group studies 88<br />
parasympathomimetic drugs, adverse effects on<br />
lungs 243<br />
parathyroid hormone 297<br />
parenteral iron 390–1<br />
Parkinson’s syndrome 124–8<br />
INDEX 461<br />
paroxysmal supraventricular tachycardias 221–2<br />
partial agonists 7, 9<br />
�-adrenoceptor antagonists 190<br />
dose–response curves 6<br />
partial gastrectomy, iron absorption 389<br />
partial pressure, anaesthetics 145<br />
partial seizures, drugs for 134<br />
particle-mediated epidermal delivery <strong>of</strong> DNA 95<br />
PAS (para-aminosalicylic acid) 338<br />
passive diffusion<br />
drug absorption 19<br />
placenta 45<br />
passive immunity 399<br />
patient-controlled analgesia (PCA) 163<br />
PC-SPES (herbal product), withdrawal 101<br />
peak flow monitoring, asthma 235<br />
peak plasma concentration 13, 14<br />
monitoring 42<br />
renal failure 37<br />
time to (T max) 18<br />
PEG-filgrastim 394<br />
PEG-ylated interferons 349<br />
pegaptanib 428<br />
peginterferon alfa-2a, viral hepatitis 261<br />
pegvisomant 316<br />
pellagra 267<br />
penciclovir 347<br />
skin infections 417<br />
penicillamine 170, 171<br />
penicillin<br />
allergy 66<br />
intrathecal 22<br />
proximal tubular secretion 31–2<br />
penicillin G 326<br />
penicillinase 325<br />
penicillins 325–7<br />
pentamidine<br />
foscarnet <strong>and</strong> 346<br />
Pneumocystis carinii 357–8<br />
pentazocine 162<br />
peppermint oil 259<br />
pepsin, antacids on 249<br />
peptic ulcer 247–52<br />
pregnancy 49<br />
percutaneous coronary intervention 197–8, 200<br />
peripheral vascular resistance 185, 186<br />
permissive hypothesis, mood disorders 116<br />
pernicious anaemia 391<br />
peroxisome proliferator-activated receptor � 182<br />
perphenazine 254<br />
personalized medicine 79, 92<br />
pethidine 161<br />
on fetus 48<br />
pH<br />
stomach, renal disease on 35<br />
urine see urinary pH<br />
phaeochromocytoma 305<br />
pharmaceutical drug interactions 71, 74, 75<br />
pharmacodynamics 4, 6–10<br />
children 53<br />
drug interactions 71<br />
elderly patients 57–8<br />
inhalational anaesthetics 146<br />
pharmacogenetics 79–85<br />
pharmacokinetics 4–5, 11–16<br />
children 52–3<br />
drug concentration measurement 41–2<br />
drug interactions 71, 72, 75–7<br />
elderly patients 56–7<br />
formulations 18<br />
gastrointestinal disease 34<br />
gastrointestinal tract 19–20<br />
grapefruit juice on 408<br />
heart failure 34–5<br />
lithium 122<br />
liver disease 37–8, 40